Biopharma Thought Leadership Blog | AGC Biologics

Challenges & Future Opportunities in Cell & Gene Therapy Development

Written by Nick McDonald | June 30, 2023 at 7:57 PM

Learn common problems and future solutions for the ATMP industry

Senior Director of Manufacturing for cell and gene therapy in the U.S., Maggie Chen, discusses supply chain challenges, the promise of standardized viral vector platforms, the future of analytics, development and manufacturing challenges, and the future of the cell and gene therapy industry. 

 

Explore our end-to-end services for cell therapy and viral vector production

With two global sites offering full-scale cell and gene services backed by 30 years of science, our network offers expertise that no other CDMO can offer today.